Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Cyclosporine for Dry Eye in Secondary Sjogren Syndrome
NCT03865888Phase 3Completed
- Start
- Oct 2018
- Primary completion
- Feb 2019
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of tacrolimus in dry eye syndrome (DED) (2 arms). Primary endpoints: Tear film volume at 3 months, Ocular surface damage at 3 months and 1 more. Started Oct 2018; status: completed.
02
Drugs
tacrolimus
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03865888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03865888.